Axogen (AXGN) Cost of Revenue (2010 - 2026)

Axogen's Cost of Revenue history runs 17 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 12.04% year-over-year to $15.3 million in Q1 2026; TTM through Mar 2026 was $59.5 million, a 18.45% increase from a year earlier, with the FY2025 full-year figure at $57.9 million, up 27.54% from the prior year.
• Cost of Revenue fell to $15.3 million in Q1 2026 per AXGN's latest filing, from $15.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $15.5 million in Q4 2025 and bottomed at $5.5 million in Q1 2022.
• The 5-year median for Cost of Revenue is $11.8 million (2022), against an average of $10.9 million.
• Biggest YoY gain for Cost of Revenue was 116.82% in 2022; the steepest drop was 11.39% in 2022.
• Year by year, Cost of Revenue stood at $11.8 million in 2022, then decreased by 7.38% to $10.9 million in 2023, then grew by 8.52% to $11.8 million in 2024, then surged by 30.98% to $15.5 million in 2025, then declined by 1.46% to $15.3 million in 2026.
• Per Business Quant, the three latest AXGN Cost of Revenue figures stand at $15.3 million (Q1 2026), $15.5 million (Q4 2025), and $14.1 million (Q3 2025).